MedTrace Logo

Implementation of a Pharmacist-Driven Antipsychotic Deprescribing Initiative in the PACE Setting: A Pilot Study

NCT04288193 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-05-25

No results posted yet for this study

Summary

The aim of this pilot study is to determine the feasibility of implementing an antipsychotic deprescribing initiative that is driven by pharmacists working collaboratively with the Program of All-inclusive Care for the Elderly (PACE) interdisciplinary team.

Conditions

  • Behavioral and Psychiatric Symptoms of Dementia
  • Insomnia

Interventions

DRUG

Recommendation to Deprescribe

Recommendation to Deprescribe

Sponsors & Collaborators

  • Tabula Rasa HealthCare

    lead INDUSTRY

Principal Investigators

  • Veronique Michaud, PhD · Tabula Rasa HealthCare

  • Anna Furman, PharmD · Tabula Rasa HealthCare

  • Adriana Matos, PharmD · Tabula Rasa HealthCare

  • Nishita Amin, PharmD · Tabula Rasa HealthCare

  • Briana Skalski, PharmD · Tabula Rasa HealthCare

  • Sweilem Al Rihani, PhD, PharmD · Tabula Rasa HealthCare

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-19
Primary Completion
2022-05-18
Completion
2022-05-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04288193 on ClinicalTrials.gov